Impact of the SARS-CoV-2 Pandemic on Treatment Pathways and Outcomes of Esophagogastric Cancer: A Pre- Versus Post-Pandemic Comparison of International Prospective Cohort Data

Keyphrases

• 30-day Mortality 33%
• Anastomotic Leak 33%
• Cancer Patients 66%
• Change Management 33%
• Cohort Data 100%
• Composite Outcome 66%
• COVID-19 Pandemic 33%
• COVIDSurg 33%
• Esophagogastric Anastomosis 33%
• Esophagogastric Cancer 100%
• Leakage Rate 33%
• LESS Surgery 33%
• Management Pathway 33%
• Negative Resection Margin 33%
• No Significant Difference 33%
• Pandemic Data 33%
• Pandemic Management 33%
• Patient Delay 66%
• Post-pandemic 100%
• Postoperative Mortality 33%
• Postoperative Outcomes 33%
• Pre-pandemic 100%
• Prospective Cohort Study 33%
• Reoperation Rate 33%
• Resectability 33%
• Resilient 33%
• SARS-CoV-2 Pandemic 100%
• Surgical Pathway 33%
• System Stress 33%
• Treatment Delay 33%
• Treatment Outcome 100%
• Treatment Pathways 100%

Medicine and Dentistry

• Anastomosis Leakage 20%
• Cancer 20%
• COVID-19 20%
• Malignant Neoplasm 100%
• Prospective Cohort Study 20%
• Reoperation 20%
• Severe Acute Respiratory Syndrome Coronavirus 2 100%
• Surgical Anastomosis 20%
• Surgical Mortality 20%
• Therapy Delay 20%